Betahistine dihydrochloride, Vertine 16mg Tab

Product shot of Vertine 16mg Tab

THERAPEUTIC CATEGORY : Anti-Vertigo / Anti-dizziness
STRENGTH : 16 mg uncoated Tablet
SIZE : Box of 100s

FORMULATION
White to off white colored circular flat uncoated beveled edged tablets having breakline on one side and other side is plain containing 16 mg betahistine dihycdrochloride.

INDICATION
Meniere’sDisease, Miniere’s Like syndrome 9with symptoms of vertigo, tinnitus and sensorineural deafness) and vertigo of peripheral origin. Symptomatic treatment of vertigo of peripheral origin.


DOSAGE AND ADMINISTRATION
Adult Dosage The usual initial dose is 8 to 16 mg three times daily to be taken preferably with meals. The dosage should be individually adapted according to the response. Improvement can sometimes only be observed after a couple of weeks of treatment. The best results are sometimes obtained after a few months. There are indications that treatment from the onset of the disease prevents the progression of the disease and / or the loss of hearing in later phases of the disease.

CONTRAINDICATION
Hypersensitivity to any of the ingredients. Patients with active peptic ulcer. Patients with phaeochromocytoma.

PRECAUTION
Gastro-intestinal disturbances, headache and skin rashes have been reported.

ADVERSE REACTION
Gastrointestinal Disorder: in some cases mild gastric complaints have been observed. These can normally be dealt with by taking the dose during meals or by lowering the dose.
Skin and subcutaneous tissue disorders: In very rare cases cutaneous hypersensitivity reactions have been reported, in particular rash, pruritus and urticaria.

AVAILABILITY
16mg tablet: Aluminum strip containing 10 tablets. Box of 100s

STORAGE
Store at temperatures not exceeding 30° C. Protect from light and moisture.

Betaserc alternative, Serc alternative